For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Biotheranostics, Inc.

USPTO Granted Patents = 15

EPO Patents = 8

Trademarks = 8

Forward Citations = 110

Loading Chart...

Loading Chart...

5 inventors (with patents filed for the assignee):

Mark G Erlander (13 out of 54 patents)

Xiao-Jun Ma (9 out of 9 patents)

Dennis Sgroi (8 out of 12 patents)

4. Yi Zhang (6 out of 38 patents)

5. Catherine A Schnabel (6 out of 6 patents)

6. Dennis C Sgroi (0 patent)

7. Brock Schroeder (0 patent)

8. Chin-Lee Wu (0 patent)

9. Edward Enright (0 patent)

15 patents: Sort by Forward Citations

1. 12460265 - Post-treatment breast cancer prognosis (2025-11-04),

2. 12215390 - Integration of tumor characteristics with breast cancer index (2025-02-04),

3. 11549148 - Neuroendocrine tumors (2023-01-10),

4. 11530448 - Integration of tumor characteristics with breast cancer index (2022-12-20),

5. 11430544 - Identification of tumors and tissues (2022-08-30),

6. 11078538 - Post-treatment breast cancer prognosis (2021-08-03),

7. 11021754 - Tumor grading and cancer prognosis (2021-06-01),

8. 10538816 - Identification of tumors (2020-01-21),

9. 10329624 - Grading of breast cancer (2019-06-25),

10. 10253369 - Predicting likelihood of response to combination therapy (2019-04-09),

11. 9856533 - Predicting breast cancer treatment outcome (2018-01-02),

12. 9670553 - Determining tumor origin (2017-06-06),

13. 9447470 - Tumor grading and cancer prognosis (2016-09-20),

14. 7930105 - Grading of breast cancer (2011-04-19),

15. 7504214 - Predicting outcome with tamoxifen in breast cancer (2009-03-17),

Biotheranostics, Inc. is a molecular diagnostics company specializing in the development and commercialization of innovative diagnostic tests for cancer treatment. They provide clinically validated molecular biomarker tests that help healthcare professionals make more personalized treatment decisions for cancer patients. Their tests are designed to provide insights into the underlying biology of tumors, allowing for targeted therapy and improved patient outcomes. With a focus on precision medicine, Biotheranostics aims to improve the standard of care and contribute to the advancement of cancer diagnostics.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

15 Patents

#354 in San Diego, CA

#4,873 in California

#20,434 in US

#38,722 in the World

San Diego, CA, United States of America

Biotheranostics, Inc.

Forward Citations = 110

5 inventors:

Mark G Erlander (13 out of 54 patents)

Xiao-Jun Ma (9 out of 9 patents)

Dennis Sgroi (8 out of 12 patents)

4. Yi Zhang (6 out of 38 patents)

5. Catherine A Schnabel (6 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…